Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immune modulation with TLR9 agonists for cancer treatment

Immune modulation with TLR9 agonists for cancer treatment

US Patent 11224611 · Granted Jan 18, 2022

Estimated economic value: $907,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic compositions for treating pain via multiple targets2024
Compositions and methods for inhibiting TIGIT gene expression2022
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2019
Immune modulation with TLR9 agonists for cancer treatment2019
Immune modulation with TLR9 agonists for cancer treatment2019
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor2018